Extrapyramidal effects of methanandamide, an analog of anandamide, the endogenous CB1 receptor ligand

Life Sciences

Volumn 58, Issue 15, 1996, Pages 1249-1257

  Romero, J ^a   Garcia Palomero E ^b   Lin, S Y ^b   Ramos, J A ^a   Makriyannis, A ^b   Fernandez Ruiz J J ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF CONNECTICUT   (United States)

Author keywords

( ) 9 tetrahydrocannabinol; Anandamide; Cannabinoid receptor; Motor activity; R methanandamide; Stereotypic behavior

Indexed keywords

ANANDAMIDE; ANANDAMIDE DERIVATIVE; ARACHIDONIC ACID; CANNABINOID 1 RECEPTOR; CANNABINOID RECEPTOR; DRONABINOL; ETHANOLAMINE; METHANANDAMIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOSE TIME EFFECT RELATION; DRUG STABILITY; EXTRAPYRAMIDAL SYSTEM; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NONHUMAN; OPEN FIELD BEHAVIOR; RAT; STEREOTYPY;

EID: 0342832962     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/0024-3205(96)00086-0     Document Type: Article

References (26)

1. J.J. FERNANDEZ-RUIZ, F. RODRIGUEZ, M. NAVARRO and J.A. RAMOS, Neurobiology and Neurophysiology of cannabinoids. Biochemistry and Physiology of substance abuse, A. Bartke and L. Murphy (eds), 119-162, CRC Press (1992).
2. J.J. FERNANDEZ-RUIZ, A. BONNIN, M. CEBEIRA and J.A. RAMOS, Strategies for studying brain disorders, T. Palomo and T. Archer (eds), vol 1, 357-390, Farrand Press (1994).
3. M. HERKENHAM, A.B. LYNN, M.D. LITTLE, M.R. JOHNSON, L.S. MELVIN, B.R. DE COSTA and K.C. RICE, PNAS (USA) 87 1932-1936 (1990).
4. M. HERKENHAM, A.B. LYNN, M.R. JOHNSON, L.S. MELVIN, B.R. DE COSTA and K.C. RICE, J. Neurosci. 11 563-583 (1991).
5. A.C. HOWLETT, M. BIDAUT-RUSELL, W.A. DEVANE, L.S. MELVIN, M.R. JOHNSON and M. HERKENHAM, TINS 13 420-423 (1990).
6. W.A. DEVANE, L. HANUS, A. BREUER, R.G. PERTWEE, L.A. STEVENSON, G. GRIFFIN, D. GIBSON, A. MANDELBAUM, A, ETINGER AND R. MECHOULAM, Science 258 1946-1949 (1992).
7. L. HANUS, A. GOPHER, S. ALMOG and R. MECHOULAM, J. Med. Chem. 36 3032-3034 (1993).
8. R. MECHOULAM, L. HANUS and B.R. MARTIN, Biochem. Pharmacol. 48 1537-1544 (1994).
9. A.C. HOWLETT, Ann. Rev. Pharmacol. Toxicol. 35 607-634 (1995).
10. R.G. PERTWEE, S.G. GREENTREE and P.A. SWIFT, Neuropharmacology 27 1256-1270 (1988).
11. D.F. MOSS, S.B. MCMASTER and J. ROGERS, Pharmacol. Biochem. Behav. 15 779-783 (1981).
12. M. NAVARRO, J.J. FERNANDEZ-RUIZ, R. DE MIGUEL, M.L. HERNANDEZ, M. CEBEIRA and J.A. RAMOS, Pharmacol. Biochem. Behav. 45 291-298 (1993).
13. F. RODRIGUEZ, M.A. GORRITI, J.J. FERNANDEZ-RUIZ, T. PALOMO and J.A. RAMOS, Pharmacol. Biochem. Behav. 47 33-40 (1994).
14. M. NAVARRO, F. RODRIGUEZ, M.L. HERNANDEZ, J.A. RAMOS and J.J. FERNANDEZ-RUIZ, Pharmacol. Biochem. Behav. 47 47-58 (1994).
15. E. FRIDE and R. MECHOULAM, Eur. J. Pharmacol. 231 313-314 (1993).
16. J.N. CRAWLEY, R.L. CORWIN, J.K. ROBINSON, C.C. FELDER W.A. DEVANE and J. AXELROD, Pharmacol. Biochem. Behav. 46 967-972 (1993).
17. P.B. SMITH, D.R. COMPTON, S.P. WELCH, R.K. RAZDAN, R. MECHOULAM and B.R. MARTIN, J. Pharmacol. Exp. Ther. 270 219-227 (1994).
18. A.P. WICKENS and R.G. PERTWEE, Eur. J. Pharmacol. 250 205-208 (1993).
19. J. SOUILHAC, M. PONCELET, M. RINALDI-CARMONA, G. LE FUR and P. SOUBRIE, Pharmacol. Biochem. Behav. 51 3-7 (1995).
20. E. FRIDE, J. BARG, R. LEVY, D. SAYA, E. HELDMAN, R. MECHOULAM and Z. VOGEL, J. Pharmacol. Exp. Ther. 272 699-707 (1995).
21. J. ROMERO, L. GARCIA, M. CEBEIRA, D. ZADROZNY, J.J. FERNANDEZ-RUIZ and J.A. RAMOS, Life Sci. 56 2033-2040 (1995).
22. J. ROMERO, R. DE MIGUEL, E. GARCIA-PALOMERO, J.J. FERNANDEZ-RUIZ and J.A. RAMOS, Brain Res. 694 223-232 (1995).
23. M. HERKENHAM, A.B. LYNN, B.R. DE COSTA and E.K. RICHFIELD, Brain Res. 547 267-274 (1991).
24. P. MAILLEUX and J.J. VANDERHAEGHEN, Neuroscience 48 655-668 (1992).
25. V. ABADJI, S. LIN, G. TAHA, G, GRIFFIN, L.A. STEVENSON, R.G. PERTWEE and A. MAKRIYANNIS, J. Med. Chem. 37 1889-1893 (1994).
26. D.G. DEUTSCH and S.A. CHIN, Biochem. Pharmacol. 46 791-796 (1993).